ReviewJournal of neurochemistry2026
Prefrontal Cortex Dysfunction as a Precipitating Factor for Schizophrenia and Depression.
Review in Journal of neurochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The effects of chemotherapy on brain regions: implications for chemobrain revealed through metabolomic profiling.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
- Vast cellular gene-expression atlas could transform how scientists understand brain ageing and disease.Nature · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The prefrontal cortex (PFC) is critical for regulating stress responses through top-down control over limbic and subcortical structures. The PFC undergoes a prolonged developmental process that only reaches maturation during adulthood, causing it to be highly sensitive to environmental insults during neurodevelopment, such as adolescence. During this critical period, synaptic pruning, the maturation of inhibitory GABAergic interneurons, and the refinement of dopaminergic transmission collectively establish the excitatory-inhibitory balance necessary for adaptive behavior. Impairment of the PFC due to developmental disruptions increases susceptibility to maladaptive stress responses. These responses can, in turn, contribute to the development of major depressive disorder and schizophrenia. In depression, a dysfunctional PFC fails to effectively inhibit the amygdala, which contributes to hyperactivity in stress-related circuits, hypodopaminergic states, and anhedonia. In schizophrenia, a neurodevelopmental PFC dysfunction would precipitate hippocampal circuit disruption driven by stress. The inability of an immature PFC to regulate the amygdala response to stress would trigger an increased excitatory drive to the ventral hippocampus, which is proposed to underlie the excessive limbic drive, hippocampal hyperactivity, and a hyperdopaminergic state. In addition, the activation of the mesocortical dopaminergic system by stress facilitates the PFC response to stress, both during adulthood and adolescence. A dopamine (DA)-induced unregulated stress response disrupts the excitatory and inhibitory transmission within the PFC, which plays a critical role in its function. Understanding the interplay between stress and PFC activity/maturation to regulate the circuit toward adaptive or maladaptive outcomes offers critical insights for early intervention and prevention. Early changes in the PFC could underlie vulnerability to unregulated stress response and its consequent effect in contributing to schizophrenia and depression. In this way, early intervention may limit the impact and prevent further circuit dysregulation leading to pathological states.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.